跳至主要内容
临床试验/NL-OMON24486
NL-OMON24486招募中不适用

Monitor Immune Microenvironment and systemic immune effects in pediatric Brain tumors

Princess Máxima Center for Pediatric Oncology0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age 0 – 18 years at inclusion
  • - Newly diagnosed brain tumor or relapse of a brain tumor
  • - MRI representing an image of a high grade brain tumor (high grade glioma, ependymoma, ATRT, medulloblastoma, or otherwise high grade) OR CNS tumor where based on MRI images the judgement of high grade versus low grade can’t be made. NB in case MRI imaging prior to biopsy and/or resection is not feasible, the patient can be included based on CT imaging and clinical assessment
  • - Clinical indication for tumor biopsy/resection
  • - Written (parental) informed consent

排除标准

  • - Suspected germ cell tumor on radiology or based on tumor markers (aFP, ßHCG)
  • - Suspected craniopharyngioma on radiology
  • - Clear characteristics of low grade tumor

研究者

发起方
Princess Máxima Center for Pediatric Oncology

相似试验